Technology | 2007.02.20
Positive Research Findings Accelerate HepaLife's Development of Artificial Liver Device
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today announced the appointment of Stem Cell Systems GmbH (Germany) among plans to accelerate
For more information, please visit
http://home.businesswire.com/portal/site[...]=en&ndmConfigId=1001385&vnsId=
Follow us on
📊 Most Viewed News
- • The complete guide to making your product international - The Nex... (15,545)
- • Colaboração 2.0: Breaking Down the Language Barrier - Business ... (12,043)
- • A Start-Up Bets on Human Translators Over Machines - New York Tim... (11,537)
- • Immigrants 'should learn English' - Politics.co.uk (11,237)
- • How OpenStack gets translated - opensource.com (11,062)
- • easyJet Chooses TransPerfect for Pan-European Translation - Busin... (10,939)
- • Phrase Named a Leader by Independent Analyst Firm (10,448)
- • Para-Plus Translations Honored by Philadelphia Business Journal .... (10,370)